<DOC>
	<DOCNO>NCT00896610</DOCNO>
	<brief_summary>Background : - Diabetes disease define abnormally high blood sugar ( glucose ) level . Glucose essential source energy body cell , insulin require move glucose cell . Insulin hormone produce pancreas allows glucose enter cell . - In diabetes , body unable supply enough insulin meet demand . The problem may low supply insulin high demand insulin . Someone diagnose diabetes lose much insulin-producing capacity . Clinical study show good control blood sugar essential prevent diabetes complication like damage eye , kidney , nerve , blood vessel . Objectives : - To establish relationship several individual diabetes cause immune system attack body insulin-producing cell order : - Explore immune system attack insulin-producing cell . - Understand individual develop diabetes-related complication others . - Develop therapy improve patient control blood sugar level . - Continue follow subject complete consider NIH diabetes-related study . - To develop improved test determine individual risk develop diabetes and/or accurately diagnose exact type diabetes . Eligibility : - Individuals diagnose risk develop diabetes . Design : - Standard physical examination clinical test determine patient diabetes confirm particular type diabetes : - None treatment study experimental . - Patients receive separate consent form special test need learn particular type diabetes . - Patients may ask provide additional urine blood sample use laboratory research diabetes . - Researchers may offer medical treatment advice diabetes , explain improve patient diabetes management skill .</brief_summary>
	<brief_title>Natural History Autoimmune Diabetes Its Complications</brief_title>
	<detailed_description>Individuals know suspect autoimmune mediate diabetes , healthy individual risk develop disease , evaluate NIH Clinical Center . Studies include characterize disease clinical laboratory feature , observe natural history disease complication , evaluate response standard treatment . Protocol enrollee may ask contribute blood and/or urine sample immunological research study , and/or study design find parameter increase subject risk diabetes and/or associate complication .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Autoimmune Diseases</mesh_term>
	<criteria>INCLUSION CRITERIA : . Clinical diagnosis diabetes , either type 1 ( T1D ) insulinrequiring type 2 ( T2D ) , ii . Healthy individual may risk develop diabetes , iii . Individuals suspect immune mediate diabetes , iv . Willingness patient guardian give inform consent assent . EXCLUSION CRITERIA : i. Concomitant medical problem would confound interpretation study autoimmune beta cell destructive process ii . Concomitant medical , surgical , condition adequate facility fund available support care NIH . iii . Any coexisting condition/circumstances would make subject unsuitable participate study , deem investigator .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 16, 2017</verification_date>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Type 1 Diabetes</keyword>
	<keyword>Complications</keyword>
	<keyword>Anti Beta-Cell Autoantibodies</keyword>
	<keyword>T-Lymphocyte Assays</keyword>
	<keyword>Type 2 Diabetes</keyword>
	<keyword>Autoimmune Diabetes</keyword>
	<keyword>At Risk Diabetes</keyword>
</DOC>